Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Devilee

Showing results (91-100 of 282) with videos related to

Pageof 29
Sort By:
Familial Cancer|January 22, 2015
High-resolution melting (HRM) re-analysis of a polyposis patients cohort reveals previously undetected heterozygous and mosaic APC gene mutationsAstrid A Out, Ivonne J H M van Minderhout, Nienke van der Stoep, et al.
Human Mutation|October 21, 2009
Deep sequencing to reveal new variants in pooled DNA samplesAstrid A Out, Ivonne J H M van Minderhout, Jelle J Goeman, et al.
Breast Cancer Research : BCR|November 14, 2007
Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer casesPetra E A Huijts, Maaike P G Vreeswijk, Karin H G Kroeze-Jansema, et al.
Genes, Chromosomes & Cancer|July 30, 2008
Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locusRogier A Oldenburg, Karin H G Kroeze-Jansema, Jeanine J Houwing-Duistermaat, et al.
International Journal of Cancer|December 4, 2004
NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in RussiaKonstantin G Buslov, Aglaya G Iyevleva, Elena V Chekmariova, et al.
Oncotarget|October 17, 2015
Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumorsAttje S Hoekstra, Marieke A de Graaff, Inge H Briaire-de Bruijn, et al.
Breast Cancer Research : BCR|July 20, 2011
Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10Petra E A Huijts, Minka van Dongen, Moniek C M de Goeij, et al.
European Journal of Cancer (Oxford, England : 1990)|June 2, 2006
High frequency of BRCA1 5382insC mutation in Russian breast cancer patientsAnna P Sokolenko, Natalia V Mitiushkina, Konstantin G Buslov, et al.
Nature Communications|March 4, 2014
Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signallingFangFang Zhou, Yvette Drabsch, Tim J A Dekker, et al.
Journal of Medical Genetics|September 26, 2022
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on <i>RAD51C</i>, <i>RAD51D</i>, <i>BARD1</i> updates to tumour pathology and cancer incidenceAndrew Lee, Nasim Mavaddat, Alex Cunningham, et al.
Pageof 29

Showing results (91-100 of 282) with videos related to

Sort By:
Pageof 29
Familial Cancer|January 22, 2015
High-resolution melting (HRM) re-analysis of a polyposis patients cohort reveals previously undetected heterozygous and mosaic APC gene mutationsAstrid A Out, Ivonne J H M van Minderhout, Nienke van der Stoep, et al.
Human Mutation|October 21, 2009
Deep sequencing to reveal new variants in pooled DNA samplesAstrid A Out, Ivonne J H M van Minderhout, Jelle J Goeman, et al.
Breast Cancer Research : BCR|November 14, 2007
Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer casesPetra E A Huijts, Maaike P G Vreeswijk, Karin H G Kroeze-Jansema, et al.
Genes, Chromosomes & Cancer|July 30, 2008
Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locusRogier A Oldenburg, Karin H G Kroeze-Jansema, Jeanine J Houwing-Duistermaat, et al.
International Journal of Cancer|December 4, 2004
NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in RussiaKonstantin G Buslov, Aglaya G Iyevleva, Elena V Chekmariova, et al.
Oncotarget|October 17, 2015
Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumorsAttje S Hoekstra, Marieke A de Graaff, Inge H Briaire-de Bruijn, et al.
Breast Cancer Research : BCR|July 20, 2011
Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10Petra E A Huijts, Minka van Dongen, Moniek C M de Goeij, et al.
European Journal of Cancer (Oxford, England : 1990)|June 2, 2006
High frequency of BRCA1 5382insC mutation in Russian breast cancer patientsAnna P Sokolenko, Natalia V Mitiushkina, Konstantin G Buslov, et al.
Nature Communications|March 4, 2014
Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signallingFangFang Zhou, Yvette Drabsch, Tim J A Dekker, et al.
Journal of Medical Genetics|September 26, 2022
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on <i>RAD51C</i>, <i>RAD51D</i>, <i>BARD1</i> updates to tumour pathology and cancer incidenceAndrew Lee, Nasim Mavaddat, Alex Cunningham, et al.
Pageof 29